|
|
|
Insider
Information: |
Crocker Gary L |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
133,105 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$2,013,879 |
|
|
Total
Shares |
133,105 |
|
|
Total
Value |
$2,013,879 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
19.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Merrimack Pharmaceuticals Inc |
MACK |
|
2020-07-22 |
0 |
2023-08-11 |
133,105 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$449,995 |
D/D |
64,285 |
64,285 |
2.39 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-04-03 |
4 |
B |
$7.00 |
$529,991 |
I/I |
75,713 |
139,998 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
925,359 |
1,065,357 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-04-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,364,674 |
2,430,031 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-09-14 |
4 |
B |
$8.32 |
$539,609 |
I/I |
64,800 |
2,494,831 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-12-13 |
4 |
B |
$6.77 |
$247,215 |
I/I |
36,500 |
2,531,331 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-12-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
129,090 |
2,441,241 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2012-12-19 |
5 |
GA |
$0.00 |
$0 |
I/I |
69,030 |
2,471,271 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2013-11-27 |
4 |
B |
$3.71 |
$769,536 |
I/I |
207,000 |
2,678,271 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-03-12 |
4 |
OE |
$1.25 |
$62,500 |
D/D |
50,000 |
2,728,271 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-05 |
4 |
B |
$6.69 |
$66,900 |
I/I |
10,000 |
2,738,271 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-05 |
4 |
OE |
$1.25 |
$43,750 |
D/D |
35,000 |
2,773,271 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-05 |
4 |
B |
$6.92 |
$69,200 |
D/D |
10,000 |
2,783,271 |
2.39 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-06 |
4 |
B |
$6.85 |
$51,375 |
I/I |
7,500 |
2,790,771 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-07 |
4 |
B |
$6.77 |
$29,788 |
I/I |
4,400 |
2,795,171 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-16 |
4 |
B |
$6.63 |
$22,542 |
I/I |
3,400 |
2,798,571 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-19 |
4 |
B |
$6.71 |
$40,260 |
D/D |
6,000 |
2,804,571 |
2.39 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-05-20 |
4 |
B |
$6.69 |
$26,760 |
D/D |
4,000 |
2,808,571 |
2.39 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-06-23 |
4 |
B |
$6.84 |
$246,240 |
I/I |
36,000 |
2,844,571 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-11-12 |
4 |
B |
$8.62 |
$49,651 |
I/I |
5,760 |
2,850,331 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2014-11-13 |
4 |
B |
$8.37 |
$72,233 |
I/I |
8,630 |
2,858,961 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
Director |
|
2015-04-02 |
4 |
OE |
$1.71 |
$183,350 |
D/D |
85,000 |
2,943,961 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
See Remarks |
|
2020-07-22 |
4 |
S |
$3.04 |
$362,903 |
D/D |
(117,963) |
0 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
See Remarks |
|
2020-07-22 |
4 |
S |
$3.04 |
$233,562 |
I/I |
(75,546) |
0 |
0 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
See Remarks |
|
2021-02-10 |
4 |
B |
$7.64 |
$26,757 |
I/I |
3,500 |
3,500 |
2.66 |
- |
|
68 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|